174 related articles for article (PubMed ID: 1446495)
1. Diagnostic value of sialic acid in malignant pleural effusions.
Imecik O; Ozer F
Chest; 1992 Dec; 102(6):1819-22. PubMed ID: 1446495
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic efficiency of serum lipid-bound sialic acid level in malignant pleural effusions].
Bektemür G; Ozer F; Kanat F; Imecik O
Tuberk Toraks; 2003; 51(3):265-70. PubMed ID: 15143404
[TBL] [Abstract][Full Text] [Related]
3. Sialic acid value in pleural effusion as a diagnostic marker of malignancy.
Alsayed S; Marzouk S
J Egypt Soc Parasitol; 2013 Dec; 43(3):689-96. PubMed ID: 24640868
[TBL] [Abstract][Full Text] [Related]
4. Serum and pleural fluid levels of alpha-L-fucosidase and sialic acid have no diagnostic value in malignant pleural effusions.
Aktoğu S; Erkizan O; Yorgancioğlu A; Bozkaya G
Monaldi Arch Chest Dis; 1997 Apr; 52(2):118-20. PubMed ID: 9203806
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of sialic acid in pleural effusion.
Bansal A; Tandon S; Kharb S
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):349-51. PubMed ID: 20677563
[TBL] [Abstract][Full Text] [Related]
6. Pleural fluid pseudouridine in malignant and benign pleural effusions.
Mak TW; Ho SS; Ho CS; Jones MG; Lai CK; Lam CW
Ann Clin Biochem; 1998 Jan; 35 ( Pt 1)():94-8. PubMed ID: 9463745
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tumor-associated antigens and total sialic acid levels in effusions of malignant and benign origin.
Yenisey C; Yenice S; Güner G; Güner S
Biochem Soc Trans; 1996 May; 24(2):301S. PubMed ID: 8736959
[No Abstract] [Full Text] [Related]
8. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
[TBL] [Abstract][Full Text] [Related]
9. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
10. Soluble receptor-binding cancer antigen expressed on SiSo cells in pleural fluid: a potential diagnostic marker for malignant pleural effusion.
Aoe K; Hiraki A; Maeda T; Murakami T; Yamazaki K; Sugi K; Takeyama H
Chest; 2004 Oct; 126(4):1195-7. PubMed ID: 15486382
[TBL] [Abstract][Full Text] [Related]
11. Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma.
Atagi S; Ogawara M; Kawahara M; Sakatani M; Furuse K; Ueda E; Yamamoto S
Jpn J Clin Oncol; 1997 Oct; 27(5):293-7. PubMed ID: 9390204
[TBL] [Abstract][Full Text] [Related]
12. [Potential role of cholesterol in distinguishing malignant from benign pleural effusion].
Plavec G; Tomić I; Nidzović N; Radojcić B; Aćimović S; Bokun R
Vojnosanit Pregl; 2004; 61(6):607-11. PubMed ID: 15717721
[TBL] [Abstract][Full Text] [Related]
13. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
Castaño Vidriales JL; Amores Antequera C
Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
Zhou WB; Bai M; Jin Y
Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
[TBL] [Abstract][Full Text] [Related]
16. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
Porcel JM; Salud A; Vives M; Esquerda A; Rodríguez-Panadero F
Clin Biochem; 2005 Nov; 38(11):1031-3. PubMed ID: 15925354
[TBL] [Abstract][Full Text] [Related]
17. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.
Pettersson T; Fröseth B; Riska H; Klockars M
Chest; 1988 Nov; 94(5):1037-9. PubMed ID: 3180855
[TBL] [Abstract][Full Text] [Related]
18. Sialic acid as a marker for differentiation between benign and malignant intracranial tumors.
Marth E; Flaschka G; Stiegler S; Möse JR
Clin Chim Acta; 1988 Sep; 176(3):251-7. PubMed ID: 3180477
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin is unsuitable as a tumor marker in pleural effusions.
Delpuech P; Desch G; Fructus F
Clin Chem; 1989 Jan; 35(1):166-8. PubMed ID: 2910559
[TBL] [Abstract][Full Text] [Related]
20. Different expression of FoxM1 in human benign and malignant pleural effusion.
Tang Z; Li H; Zhu H; Bai C
Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
